efgartigimod

FDA Drug Profile

Drug Details

Generic Name
efgartigimod
Brand Names
N/A
Application Number
Sponsor
Lonza Biologics, plc
NDC Codes
1
Dosage Forms
LIQUID
Routes
N/A
Active Ingredients
EFGARTIGIMOD ALFA

Indications and Usage

1 INDICATIONS AND USAGE VYVGART is indicated for the treatment of generalized myasthenia gravis (gMG) in adult patients who are anti-acetylcholine receptor (AChR) antibody positive. VYVGART is a neonatal Fc receptor blocker indicated for the treatment of generalized myasthenia gravis (gMG) in adult patients who are anti-acetylcholine receptor (AChR) antibody positive. ( 1 )